Amneal Pharmaceuticals Inc. (AMRX)

Amneal Pharmaceuticals Inc. (AMRX $7.96)
- $7.96 Cap: $2.58B
- View AMRX Profile
- View Questions on AMRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amneal Pharmaceuticals Inc. (AMRX $7.96)
- $7.96 Cap: $2.58B
- View AMRX Profile
- View Questions on AMRX

Q: Amneal Pharmaceuticals spiralled downward in October 2018, and has been essentially flatlining in the $4-$5 range since 2020. In the generic pharma business, one would think this should be doing somewhat better than it is. Any signs of a recovery on this one? Thanks.

Read Answer Asked by Sylvia on October 25, 2023